Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriam Labopin

Showing results (21-30 of 442) with videos related to

Pageof 45
Sort By:
Bone Marrow Transplantation|June 19, 2026
Time to resolution of veno-occlusive disease/sinusoidal obstruction syndrome post-HCT in defibrotide-treated adults from two European registriesMohamad Mohty, Régis Peffault de Latour, Myriam Labopin, et al.
Leukemia Research|December 3, 2014
Prognosis of body mass index and chemotherapy dose capping in acute myeloid leukaemiaEmmanuelle Kempf, Pierre Hirsch, Myriam Labopin, et al.
The Lancet. Gastroenterology & Hepatology|May 13, 2017
Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trialJames O Lindsay, Mathieu Allez, Miranda Clark, et al.
Bone Marrow Transplantation|August 27, 2025
Definition of relapse criteria in patients with rapidly progressive systemic sclerosis treated with autologous haemopoietic stem cell transplantationNicoletta Del Papa, Myriam Labopin, Manuela Badoglio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2002
Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European surveyVanderson Rocha, Myriam Labopin, Eliane Gluckman, et al.
Cancer|March 21, 2013
Increase of suicide and accidental death after hematopoietic stem cell transplantation: a cohort study on behalf of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation (EBMT)André Tichelli, Myriam Labopin, Alicia Rovó, et al.
Cancer|November 28, 2019
Stem cell transplantation from a haploidentical donor versus a genoidentical sister for adult male patients with acute myelogenous leukemia in first remission: A retrospective study from the acute leukemia working party of the European Society for Blood and Marrow TransplantationNorbert-Claude Gorin, Myriam Labopin, Didier Blaise, et al.
Cancer|May 9, 2014
Extreme heterogeneity of myeloablative total body irradiation techniques in clinical practice: a survey of the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationSebastian Giebel, Leszek Miszczyk, Krzysztof Slosarek, et al.
American Journal of Hematology|April 13, 2018
Optimizing the pretransplant regimen for autologous stem cell transplantation in acute myelogenous leukemia: Better outcomes with busulfan and melphalan compared with busulfan and cyclophosphamide in high risk patients autografted in first complete remission: A study from the acute leukemia working party of the EBMTNorbert Claude Gorin, Myriam Labopin, Didier Blaise, et al.
JAMA Oncology|November 27, 2018
Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European PatientsAndré Tichelli, Eric Beohou, Myriam Labopin, et al.
Pageof 45

Showing results (21-30 of 442) with videos related to

Sort By:
Pageof 45
Bone Marrow Transplantation|June 19, 2026
Time to resolution of veno-occlusive disease/sinusoidal obstruction syndrome post-HCT in defibrotide-treated adults from two European registriesMohamad Mohty, Régis Peffault de Latour, Myriam Labopin, et al.
Leukemia Research|December 3, 2014
Prognosis of body mass index and chemotherapy dose capping in acute myeloid leukaemiaEmmanuelle Kempf, Pierre Hirsch, Myriam Labopin, et al.
The Lancet. Gastroenterology & Hepatology|May 13, 2017
Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trialJames O Lindsay, Mathieu Allez, Miranda Clark, et al.
Bone Marrow Transplantation|August 27, 2025
Definition of relapse criteria in patients with rapidly progressive systemic sclerosis treated with autologous haemopoietic stem cell transplantationNicoletta Del Papa, Myriam Labopin, Manuela Badoglio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2002
Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European surveyVanderson Rocha, Myriam Labopin, Eliane Gluckman, et al.
Cancer|March 21, 2013
Increase of suicide and accidental death after hematopoietic stem cell transplantation: a cohort study on behalf of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation (EBMT)André Tichelli, Myriam Labopin, Alicia Rovó, et al.
Cancer|November 28, 2019
Stem cell transplantation from a haploidentical donor versus a genoidentical sister for adult male patients with acute myelogenous leukemia in first remission: A retrospective study from the acute leukemia working party of the European Society for Blood and Marrow TransplantationNorbert-Claude Gorin, Myriam Labopin, Didier Blaise, et al.
Cancer|May 9, 2014
Extreme heterogeneity of myeloablative total body irradiation techniques in clinical practice: a survey of the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationSebastian Giebel, Leszek Miszczyk, Krzysztof Slosarek, et al.
American Journal of Hematology|April 13, 2018
Optimizing the pretransplant regimen for autologous stem cell transplantation in acute myelogenous leukemia: Better outcomes with busulfan and melphalan compared with busulfan and cyclophosphamide in high risk patients autografted in first complete remission: A study from the acute leukemia working party of the EBMTNorbert Claude Gorin, Myriam Labopin, Didier Blaise, et al.
JAMA Oncology|November 27, 2018
Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European PatientsAndré Tichelli, Eric Beohou, Myriam Labopin, et al.
Pageof 45